196 related articles for article (PubMed ID: 21800826)
21. Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin.
Desai UR; Petitou M; Björk I; Olson ST
J Biol Chem; 1998 Mar; 273(13):7478-87. PubMed ID: 9516447
[TBL] [Abstract][Full Text] [Related]
22. New antithrombin-based anticoagulants.
Desai UR
Med Res Rev; 2004 Mar; 24(2):151-81. PubMed ID: 14705167
[TBL] [Abstract][Full Text] [Related]
23. Role of arginine 129 in heparin binding and activation of antithrombin.
Desai U; Swanson R; Bock SC; Bjork I; Olson ST
J Biol Chem; 2000 Jun; 275(25):18976-84. PubMed ID: 10764763
[TBL] [Abstract][Full Text] [Related]
24. Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides.
Al-Horani RA; Desai UR
J Med Chem; 2014 Jun; 57(11):4805-18. PubMed ID: 24844380
[TBL] [Abstract][Full Text] [Related]
25. The effect of a reducing-end extension on pentasaccharide binding by antithrombin.
Belzar KJ; Dafforn TR; Petitou M; Carrell RW; Huntington JA
J Biol Chem; 2000 Mar; 275(12):8733-41. PubMed ID: 10722716
[TBL] [Abstract][Full Text] [Related]
26. Sulfated galactan is a catalyst of antithrombin-mediated inactivation of alpha-thrombin.
Melo FR; Pereira MS; Monteiro RQ; Foguel D; Mourão PA
Biochim Biophys Acta; 2008 Sep; 1780(9):1047-53. PubMed ID: 18558097
[TBL] [Abstract][Full Text] [Related]
27. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin.
Chuang YJ; Swanson R; Raja SM; Olson ST
J Biol Chem; 2001 May; 276(18):14961-71. PubMed ID: 11278930
[TBL] [Abstract][Full Text] [Related]
28. Disruption of a tight cluster surrounding tyrosine 131 in the native conformation of antithrombin III activates it for factor Xa inhibition.
dela Cruz RG; Jairajpuri MA; Bock SC
J Biol Chem; 2006 Oct; 281(42):31668-76. PubMed ID: 16940049
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM
Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565
[TBL] [Abstract][Full Text] [Related]
30. The role of Arg46 and Arg47 of antithrombin in heparin binding.
Arocas V; Bock SC; Olson ST; Björk I
Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
[TBL] [Abstract][Full Text] [Related]
31. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
Fan B; Turko IV; Gettins PG
Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
Desai UR; Petitou M; Björk I; Olson ST
Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884
[TBL] [Abstract][Full Text] [Related]
33. Residues Tyr253 and Glu255 in strand 3 of beta-sheet C of antithrombin are key determinants of an exosite made accessible by heparin activation to promote rapid inhibition of factors Xa and IXa.
Izaguirre G; Olson ST
J Biol Chem; 2006 May; 281(19):13424-13432. PubMed ID: 16517611
[TBL] [Abstract][Full Text] [Related]
34. Heparin-activated antithrombin interacts with the autolysis loop of target coagulation proteases.
Yang L; Manithody C; Rezaie AR
Blood; 2004 Sep; 104(6):1753-9. PubMed ID: 15178583
[TBL] [Abstract][Full Text] [Related]
35. Serine 380 (P14) --> glutamate mutation activates antithrombin as an inhibitor of factor Xa.
Futamura A; Gettins PG
J Biol Chem; 2000 Feb; 275(6):4092-8. PubMed ID: 10660568
[TBL] [Abstract][Full Text] [Related]
36. Antithrombotic potencies of heparins in relation to their antifactor Xa and antithrombin activities: an experimental study in two models of thrombosis in the rabbit.
Amar J; Caranobe C; Sie P; Boneu B
Br J Haematol; 1990 Sep; 76(1):94-100. PubMed ID: 2223652
[TBL] [Abstract][Full Text] [Related]
37. Kinetic evidence that allosteric activation of antithrombin by heparin is mediated by two sequential conformational changes.
Schedin-Weiss S; Richard B; Olson ST
Arch Biochem Biophys; 2010 Dec; 504(2):169-76. PubMed ID: 20816747
[TBL] [Abstract][Full Text] [Related]
38. Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation.
Beauchamp NJ; Pike RN; Daly M; Butler L; Makris M; Dafforn TR; Zhou A; Fitton HL; Preston FE; Peake IR; Carrell RW
Blood; 1998 Oct; 92(8):2696-706. PubMed ID: 9763552
[TBL] [Abstract][Full Text] [Related]
39. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa bridging complex. Demonstration by rapid kinetics studies.
Rezaie AR; Olson ST
Biochemistry; 2000 Oct; 39(39):12083-90. PubMed ID: 11009624
[TBL] [Abstract][Full Text] [Related]
40. Capillary electrophoretic study of small, highly sulfated, non-sugar molecules interacting with antithrombin.
Liang A; Raghuraman A; Desai UR
Electrophoresis; 2009 May; 30(9):1544-51. PubMed ID: 19425011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
